CCL2 and systemic sclerosis: Previous studies have established a correlation between the elevated levels of CCL2 and the increased severity and progression of lung fibrosis in SSc patients [18, 19, 20, 21], notably through its association with a high HRCT fibrosis score and poorer survival compared to healthy volunteers [21, 22].